Your shopping cart is currently empty

PROTACERαDegrader-13 is an orally bioavailable, highly potent, and selective PROTAC molecule designed to degrade ERα with a DC50 of 3.78 nM. It demonstrates strong antiproliferative activity (IC50 = 0.6 nM) in MCF-7 cells and exhibits characteristics such as inducing apoptosis and overcoming drug resistance. PROTACERαDegrader-13 has been shown to have a good safety profile without notable organ toxicity, making it suitable for cancer research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | PROTACERαDegrader-13 is an orally bioavailable, highly potent, and selective PROTAC molecule designed to degrade ERα with a DC50 of 3.78 nM. It demonstrates strong antiproliferative activity (IC50 = 0.6 nM) in MCF-7 cells and exhibits characteristics such as inducing apoptosis and overcoming drug resistance. PROTACERαDegrader-13 has been shown to have a good safety profile without notable organ toxicity, making it suitable for cancer research. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.